Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis
Clinical trial NCT03297502 · COMPLETED
Trial details
- NCT number
- NCT03297502
- Sponsor
- Par Pharmaceutical, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-06-01
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.